ATRC
Price
$31.58
Change
+$0.27 (+0.86%)
Updated
Apr 7, 04:59 PM (EDT)
Capitalization
1.45B
22 days until earnings call
QTRX
Price
$5.15
Change
-$0.79 (-13.30%)
Updated
Apr 7, 04:59 PM (EDT)
Capitalization
907.82M
35 days until earnings call
Ad is loading...

ATRC vs QTRX

Header iconATRC vs QTRX Comparison
Open Charts ATRC vs QTRXBanner chart's image
AtriCure
Price$31.58
Change+$0.27 (+0.86%)
Volume$7.99K
Capitalization1.45B
Quanterix
Price$5.15
Change-$0.79 (-13.30%)
Volume$39.74K
Capitalization907.82M
ATRC vs QTRX Comparison Chart
Loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATRC vs. QTRX commentary
Apr 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATRC is a Buy and QTRX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 08, 2025
Stock price -- (ATRC: $31.31 vs. QTRX: $5.94)
Brand notoriety: ATRC and QTRX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ATRC: 89% vs. QTRX: 138%
Market capitalization -- ATRC: $1.45B vs. QTRX: $907.82M
ATRC [@Medical Specialties] is valued at $1.45B. QTRX’s [@Medical Specialties] market capitalization is $907.82M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATRC’s FA Score shows that 0 FA rating(s) are green whileQTRX’s FA Score has 1 green FA rating(s).

  • ATRC’s FA Score: 0 green, 5 red.
  • QTRX’s FA Score: 1 green, 4 red.
According to our system of comparison, QTRX is a better buy in the long-term than ATRC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATRC’s TA Score shows that 4 TA indicator(s) are bullish while QTRX’s TA Score has 4 bullish TA indicator(s).

  • ATRC’s TA Score: 4 bullish, 5 bearish.
  • QTRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, QTRX is a better buy in the short-term than ATRC.

Price Growth

ATRC (@Medical Specialties) experienced а -1.63% price change this week, while QTRX (@Medical Specialties) price change was -9.45% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -5.77%. For the same industry, the average monthly price growth was -2.12%, and the average quarterly price growth was -0.29%.

Reported Earning Dates

ATRC is expected to report earnings on Aug 05, 2025.

QTRX is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Medical Specialties (-5.77% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATRC($1.45B) has a higher market cap than QTRX($908M). ATRC YTD gains are higher at: 2.454 vs. QTRX (-44.120). ATRC has higher annual earnings (EBITDA): -8.11M vs. QTRX (-39.79M). QTRX has more cash in the bank: 321M vs. ATRC (137M). QTRX has less debt than ATRC: QTRX (41.5M) vs ATRC (74.5M). ATRC has higher revenues than QTRX: ATRC (399M) vs QTRX (121M).
ATRCQTRXATRC / QTRX
Capitalization1.45B908M159%
EBITDA-8.11M-39.79M20%
Gain YTD2.454-44.120-6%
P/E Ratio36.76N/A-
Revenue399M121M330%
Total Cash137M321M43%
Total Debt74.5M41.5M180%
FUNDAMENTALS RATINGS
ATRC vs QTRX: Fundamental Ratings
ATRC
QTRX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
69
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9191
PRICE GROWTH RATING
1..100
5593
P/E GROWTH RATING
1..100
96100
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTRX's Valuation (28) in the Pharmaceuticals Major industry is somewhat better than the same rating for ATRC (69) in the Medical Specialties industry. This means that QTRX’s stock grew somewhat faster than ATRC’s over the last 12 months.

QTRX's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as ATRC (100) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to ATRC’s over the last 12 months.

QTRX's SMR Rating (91) in the Pharmaceuticals Major industry is in the same range as ATRC (91) in the Medical Specialties industry. This means that QTRX’s stock grew similarly to ATRC’s over the last 12 months.

ATRC's Price Growth Rating (55) in the Medical Specialties industry is somewhat better than the same rating for QTRX (93) in the Pharmaceuticals Major industry. This means that ATRC’s stock grew somewhat faster than QTRX’s over the last 12 months.

ATRC's P/E Growth Rating (96) in the Medical Specialties industry is in the same range as QTRX (100) in the Pharmaceuticals Major industry. This means that ATRC’s stock grew similarly to QTRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ATRCQTRX
RSI
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 4 days ago
88%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
86%
Advances
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
89%
Bullish Trend 4 days ago
90%
Aroon
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
90%
View a ticker or compare two or three
Ad is loading...
ATRC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
QTRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSCSX14.70-0.64
-4.17%
JPMorgan US Small Company I
IGFRX20.63-1.22
-5.58%
Invesco EQV International Equity R6
TROSX12.27-0.81
-6.19%
T. Rowe Price Overseas Stock
RSMOX17.94-1.30
-6.76%
Victory RS Mid Cap Growth A
HNCYX16.21-1.21
-6.95%
Hartford International Growth Y

QTRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTRX has been loosely correlated with SIBN. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if QTRX jumps, then SIBN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTRX
1D Price
Change %
QTRX100%
-4.35%
SIBN - QTRX
45%
Loosely correlated
-0.96%
NEO - QTRX
43%
Loosely correlated
+0.69%
BLFS - QTRX
42%
Loosely correlated
-6.95%
PACB - QTRX
42%
Loosely correlated
+3.36%
FLGT - QTRX
41%
Loosely correlated
-0.82%
More